Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American ...

Ultimately, it is the assay itself that will determine the success and reliability of screening results, and thus companies are actively searching for new systems to supplement conventional drug ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

With over 15 years of experience in kinase drug discovery, DiscoverX offers the largest collection of nearly 500 biochemical ... proprietary active site-directed competition binding assay to ...

Using our CRISPR-based screening, we help companies get a wide sweep of candidates, while ensuring that the results returned stay relevant. When developing a drug, it’s important to understand ...

The company's investment in diagnostics firm Recipe is part of an effort to develop its DART mass spec tech for therapeutic drug monitoring and drugs of abuse testing.

Ottawa, April 17, 2025 (GLOBE NEWSWIRE) -- The global drug screening market size was valued at USD 6.45 billion in 2024 and is predicted to hit around USD 10.34 billion by 2034, a study published ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...